The Pharmaceutical Companies Significantly Contributing to the US Drug Discovery Informatics Market

US drug discovery informatics market is projected to grow at a significant CAGR during the forecast period (2020-2026). The significant presence of major pharmaceutical companies such as Pfizer Inc., AbbVie Inc., Eli Lilly & co., and others coupled with significant adoption of analytics solutions further provides a significant opportunity to the market. Moreover, the growing research for personalized medicine in the country is encouraging the demand for drug discovery analytics among pharmaceutical companies in the country. The US FDA had received a significant number of applications relating to the approval of personalized medicines over the past years.

Browse the full report description US Drug Discovery Informatics Market Size, Share & Trends Analysis Report by Function (Docking, Molecular Modeling, Libraries & Database Preparation, Sequencing & Target Data Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Contract Research Organizations, and Others) and Forecast 2020-2026 at https://www.omrglobal.com/industry-reports/us-drug-discovery-informatics-market

The Personalized Medicine Coalition has classified 28% of new molecular entities (NMEs) as personalized medicines in 2015, and 42% in 2018, in the US. The growing FDA approvals signify the considerable existence of researches working towards the development of personalized medicine. Personalized medicine formation requires patient-specific data to create therapeutic strategies for individual patients. In the overall process of personalized medicine formation, a large amount of data gets generated which when analyzed have the potential to enable the diagnosis, treatment, and prevention of disease at a highly personalized level. Therefore, an increase in the number of researches related to the development of personalized medicine in the country is making a considerable scope for the US drug discovery informatics market.  

Market Coverage

Key questions addressed by the report

• What is the market growth rate during the forecast period?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market during the forecast period?
• How COVID-19 will impact the market growth in 2020 and the coming years?

o Recovery Timeline

o Deviation from the pre-COVID-19 forecast

o Most affected segment

o Recommendations 

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

US Drug Discovery Informatics Market – Segmentation

By Function

• Docking
• Molecular Modeling
• Libraries and Database Preparation
• Sequencing and Target Data Analysis
• Others

By End-User

• Pharmaceutical & Biotechnology Companies
• Contract Research Organization (CRO)
• Others (Research Institutes)